BioCryst Pharmaceuticals Inc Share Price
NASDAQ: BCRXHealthcare
Live BioCryst Pharmaceuticals Inc Share Price Chart
O H L
BioCryst Pharmaceuticals Inc Performance Overview
Days Range
▼
$8.55Low
$8.69High
Markets Today
| Previous Close | $8.70 |
|---|---|
| Open | $8.55 |
| Volume | 486,739 |
| Day's Range | $8.55 - $8.69 |
| 52W Range | $6.00 - $11.22 |
| Market Cap | $2.15 B |
Historical Performance
| 1M Returns | -10.31 |
|---|---|
| 3M Returns | -3.23 |
| 6M Returns | -5.02 |
| 1Y Returns | +9.30 |
| 5Y Returns | -44.59 |
| 10Y Returns | +91.63 |
BioCryst Pharmaceuticals Inc Fundamentals
| Market Cap | $2.15 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $874.84 M |
| ROE TTM | N/A |
| EPS TTM | $-1.50 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $342.38 M |
| Profit Margin | 30.16 |
| Market Cap | $2.15 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $874.84 M |
| ROE TTM | N/A |
| EPS TTM | $-1.50 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $342.38 M |
| Profit Margin | 30.16 |
BioCryst Pharmaceuticals Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $145.53 M | $163.35 M | $159.40 M | $406.56 M | $156.41 M | $218.25 M |
| Gross Profit + | $140.97 M | $160.56 M | $157.21 M | $397.03 M | $151.04 M | $214.41 M |
| Operating Income | $21.23 M | $29.79 M | $29.59 M | $260.38 M | -$701.60 M | $98.47 M |
| EBITDA | $21.56 M | $30.11 M | $29.93 M | $260.78 M | -$700.54 M | $98.38 M |
| Interest Expense | -$23.49 M | -$21.58 M | -$19.66 M | -$14.13 M | -$19.78 M | -$21.71 M |
| Depreciation | $331.00 K | $329.00 K | $335.00 K | $394.00 K | $1.06 M | -$87.00 K |
| Income Before Tax | $758.00 K | $6.49 M | $12.13 M | $248.02 M | -$720.81 M | $79.47 M |
| Income Tax Expense | $726.00 K | $1.40 M | -$769.00 K | $2.17 M | $1.00 M | $1.08 M |
| Net Income + | $32.00 K | $5.08 M | $12.90 M | $245.84 M | -$721.81 M | $78.39 M |
| Net Profit Margin | 0.02% | 3.11% | 8.09% | 60.47% | -461.48% | 35.92% |
BioCryst Pharmaceuticals Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $2.09 M | $2.10 M | $2.10 M | $2.13 M | $2.54 M | $2.55 M |
| Reserve & Surplus | -$1.77 B | -$1.76 B | -$1.75 B | -$1.51 B | -$2.23 B | -$2.15 B |
| Non-Current Liabilities | $792.12 M | $701.62 M | $644.08 M | $437.25 M | $823.50 M | $803.29 M |
| Current Liabilities | $139.85 M | $153.91 M | $164.25 M | $196.07 M | $195.39 M | $208.85 M |
| Total Liabilities | $931.97 M | $878.78 M | $834.31 M | $633.31 M | $1.02 B | $1.01 B |
| Fixed Assets | $7.59 M | $8.46 M | $8.40 M | $8.78 M | $9.37 M | $9.06 M |
| Current Assets | $409.98 M | $398.46 M | $355.68 M | $404.35 M | $373.63 M | $484.68 M |
| Total Assets | $480.05 M | $457.19 M | $446.42 M | $514.16 M | $465.05 M | $557.85 M |
BioCryst Pharmaceuticals Inc Cash Flow
Quarterly
| Dec 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $245.84 M | $245.84 M | -$721.81 M | -$721.81 M | $78.39 M | $78.39 M |
| Operating Cash Flow | $291.96 M | $291.96 M | -$61.79 M | -$61.79 M | $104.34 M | $104.34 M |
| Investing Cash Flow | -$83.49 M | -$83.49 M | -$268.65 M | -$268.65 M | -$110.15 M | -$110.15 M |
| Financing Cash Flow | -$217.96 M | -$217.96 M | $412.55 M | $412.55 M | -$11.15 M | -$11.15 M |
| Change in Cash | $5.28 M | $5.28 M | $82.04 M | $82.04 M | -$16.99 M | -$16.99 M |
BioCryst Pharmaceuticals Inc Return Calculator
The BioCryst Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$5,503
Invested Amount$10,000
Est. Returns$-4,497
About BioCryst Pharmaceuticals Inc
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Popular Stocks
FAQs
What is the share price of BioCryst Pharmaceuticals Inc today?
BioCryst Pharmaceuticals Inc (BCRX) share price as of September 18, 2026 is $8.64. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of BioCryst Pharmaceuticals Inc?
Yes, Indian Investors can invest in the BioCryst Pharmaceuticals Inc (BCRX) Share by opening an international trading account with Angel One.
How can I purchase BioCryst Pharmaceuticals Inc shares in India?
Purchasing BioCryst Pharmaceuticals Inc (BCRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying BioCryst Pharmaceuticals Inc (BCRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of BioCryst Pharmaceuticals Inc?
Yes, you can purchase fractional shares of BioCryst Pharmaceuticals Inc (BCRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of BioCryst Pharmaceuticals Inc?
The market capitalization of BioCryst Pharmaceuticals Inc on September 18, 2026, is $2.15 B.
In which sector BioCryst Pharmaceuticals Inc belongs?
BioCryst Pharmaceuticals Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in BioCryst Pharmaceuticals Inc stocks?
In order to invest in BioCryst Pharmaceuticals Inc (BCRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
